Regan SB, Medhi D, Xu Y, White TB, Jiang Y-Z, Kim JE, Wang SC, Deng Q, Jia S, Baasan D, Connelly JP, Chang TC, Pruett-Miller SM, Jasin M (2025). Megabase-scale loss of heterozygosity provoked by CRISPR-Cas9 DNA double-strand breaks. Molecular Cell. 85:4119-4137.e10.
Azeroglu B, Khurana S, Wang SC, Tricola GM, Sharma S, Jubelin C, Cortolezzis Y, Pegoraro G, Miller KM, Stracker TH, Lazzerini Denchi E (2025). Identification of modulators of the ALT pathway through a native FISH-based optical screen. Cell Reports. 44:115114.
Kim D*, Bhargava R*, Wang SC, Tseng W-C, Lee D, Patel R, Oh S, Bowman RW, Smith BA, Kim M, Na CH, O’Sullivan RJ*, Miller KM* (2025). TRIM24 directs replicative stress responses to maintain ALT telomeres via chromatin signaling. Molecular Cell. 85:2636-2653.e8.
Li H, Liu Y, Wilson CN, Bai HJ, Jones MD, Wang SC, DeVore JE, Maier EY, Durant ST, Boufraqech M, Weyemi U (2023). CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors. Proceedings of the National Academy of Sciences (PNAS). 120:e2212072120.
